Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Bellevue Group AG
Form 13F · Q2 2026

Bellevue Group AG

CIK 1674546Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$4.8B
Reported book value
164
Positions
12
Quarters on record
Top 50
Positions

Bellevue Group AG — holdings

Top 50 positions of 164, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1AMGN Amgen Inc851,550+188.3%$308M6.5%
2VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc578,634−15.1%$287M6.0%
3ARGX Argenx Se301,000−3.8%$279M5.9%
4GILD Gilead Sciences Inc2.2M+84.5%$273M5.7%
5RVMD Revolution Medicines Inc1.0M−32.1%$196M4.1%
6ORKA Oruka Therapeutics Inc1.7M+226.9%$158M3.3%
7INSM Insmed Inc1.4M+13787.0%$149M3.1%
8SRRK Scholar Rock Hldg Corp2.4M−31.7%$135M2.8%
9NUVALENT INC Nuvalent Inc1.1M+0.0%$130M2.7%
10VRDN Viridian Therapeutics Inc6.7M+0.1%$124M2.6%
11RLAY Relay Therapeutics Inc6.2M−20.6%$116M2.4%
12PCVX Vaxcyte Inc2.0M+65.6%$115M2.4%
13UTHR United Therapeutics Corp Del188,515+8976.3%$102M2.1%
14ISRG Intuitive Surgical Inc254,809−11.1%$101M2.1%
15REGN Regeneron Pharmaceuticals157,291−43.6%$98M2.1%
16CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In2.6M−20.1%$98M2.1%
17BBIO Bridgebio Pharma Inc1.2M+4587.3%$89M1.9%
18IMCR Immunocore Hldgs Plc2.8M−0.3%$89M1.9%
19ABT Abbott Laboratories947,115−17.8%$86M1.8%
20SYK Stryker Corporation268,461+23.6%$85M1.8%
21MDT Medtronic Plc994,233+3.9%$78M1.6%
22IONS Ionis Pharmaceuticals Inc972,258−46.5%$77M1.6%
23ELVN Enliven Therapeutics Inc1.5M−35.8%$76M1.6%
24VERA Vera Therapeutics Inc1.7M+0.0%$73M1.5%
25JBIO Jade Biosciences Inc3.1M−12.7%$68M1.4%
26EW Edwards Lifesciences Corp739,234−11.9%$67M1.4%
27RARE Ultragenyx Pharmaceutical In2.0M−16.7%$66M1.4%
28UNH Unitedhealth Group Inc149,127+0.6%$62M1.3%
29DXCM Dexcom Inc822,489+4.3%$55M1.2%
30CLDX Celldex Therapeutics Inc New1.2M+0.0%$45M0.9%
31AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc1.4M—$44M0.9%
32DMRA Damora Therapeutics Inc1.6M−29.6%$42M0.9%
33IRON Disc Medicine Inc560,000+21.9%$41M0.9%
34TMO Thermo Fisher Scientific Inc79,816+23.9%$40M0.8%
35BSX Boston Scientific Corp887,650−39.5%$38M0.8%
36LLY Eli Lilly & Co29,882−11.9%$36M0.8%
37CGON Cg Oncology Inc493,596—$35M0.7%
38IDEXX LABS INC Idexx Labs Inc61,780−30.7%$33M0.7%
39RMD Resmed Inc148,195−7.0%$29M0.6%
40KRYS Krystal Biotech Inc77,530−83.9%$29M0.6%
41GLUE Monte Rosa Therapeutics Inc1.2M−4.8%$29M0.6%
42DANAHER CORP DEL Danaher Corp Del143,844−28.8%$27M0.6%
43JNJ Johnson & Johnson103,280−13.3%$26M0.6%
44SPTX Seaport Therapeutics Inc1.1M—$24M0.5%
45PVLA Palvella Therapeutics Inc Ne155,000—$24M0.5%
46ALGN Align Technology Inc139,680+0.0%$24M0.5%
47ANNX Annexon Inc4.1M−20.5%$23M0.5%
48HUM Humana Inc58,398−9.5%$23M0.5%
49ELV Elevance Health Inc Formerly56,449+7.5%$22M0.5%
50TNGX Tango Therapeutics Inc694,182−71.1%$22M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.